148 related articles for article (PubMed ID: 30941950)
21. The Fragile Histidine Triad gene and breast cancer.
Yang Q; Yoshimura G; Sakurai T; Kakudo K
Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
[TBL] [Abstract][Full Text] [Related]
22. Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood.
Tan S; Sun C; Wei X; Li Y; Wu Y; Yan Z; Feng F; Wang J; Wu Y
Exp Lung Res; 2013; 39(4-5):182-90. PubMed ID: 23614702
[TBL] [Abstract][Full Text] [Related]
23. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
24. Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer.
Ginestier C; Bardou VJ; Popovici C; Charafe-Jauffret E; Bertucci F; Geneix J; Adélaïde J; Chaffanet M; Hassoun J; Viens P; Jacquemier J; Birnbaum D
Int J Cancer; 2003 Dec; 107(5):854-62. PubMed ID: 14566838
[TBL] [Abstract][Full Text] [Related]
25. [Expressions of cyclinB1, FHIT and Ki-67 in 336 gastric carcinoma patients and their clinicopathologic significance].
Li YZ; Zhao P
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(33):2337-41. PubMed ID: 20095356
[TBL] [Abstract][Full Text] [Related]
26. The significance of fragile histidine triad protein as a molecular prognostic marker of bladder urothelial carcinoma.
Zhang CT; Lu R; Lin YL; Liu RL; Zhang ZH; Yang K; Dang RF; Zhang HT; Shen YG; Kong PZ; Ren HL; Li XL; Quan W; Xu Y
J Int Med Res; 2012; 40(2):507-16. PubMed ID: 22613411
[TBL] [Abstract][Full Text] [Related]
27. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
Zhao P; Lu Y; Zhong M; Liu L; Li B
Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
[TBL] [Abstract][Full Text] [Related]
28. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
[TBL] [Abstract][Full Text] [Related]
29. Expression and Prognostic Role of FHIT, Fibronectin, and PTEN in Hepatocellular Carcinoma.
Zhang MJ; Yan Q; Zhang GL; Wie YH; Yuan WB; Xu W; Huang LF
Clin Lab; 2016 Jul; 62(7):1255-1264. PubMed ID: 28164627
[TBL] [Abstract][Full Text] [Related]
30. FHIT Gene Expression in Acute Lymphoblastic Leukemia and its Clinical Significance.
Malak CA; Elghanam DM; Elbossaty WF
Asian Pac J Cancer Prev; 2015; 16(18):8197-201. PubMed ID: 26745060
[TBL] [Abstract][Full Text] [Related]
31. The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review.
Su Y; Wang X; Li J; Xu J; Xu L
Drug Des Devel Ther; 2015; 9():5439-45. PubMed ID: 26491255
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity in the fragile histidine triad (FHIT) locus and expression analysis of FHIT protein in patients with breast disorders.
Rabelo RA; Antunes LM; Etchebehere RM; Nomelini RS; Nascentes GA; Murta EF; Pedrosa AL
Clin Exp Obstet Gynecol; 2013; 40(1):89-94. PubMed ID: 23724516
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer.
Chava S; Mohan V; Shetty PJ; Manolla ML; Vaidya S; Khan IA; Waseem GL; Boddala P; Ahuja YR; Hasan Q
Dis Esophagus; 2012 Jan; 25(1):81-7. PubMed ID: 21668571
[TBL] [Abstract][Full Text] [Related]
34. Concordant loss of fragile gene expression early in breast cancer development.
Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K
Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374
[TBL] [Abstract][Full Text] [Related]
35. [Alterations of FHIT gene and p16 gene in lung cancer and metastatic hilar lymph nodes].
Wang X; Sun Y; Li W
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):108-11. PubMed ID: 11776848
[TBL] [Abstract][Full Text] [Related]
36. [The relationship between expression of Fhit and biological behaviors of hypopharyngeal carcinoma].
Wu H; Luan X; Zhou W; Pan X; Xu F; Lei D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Mar; 20(6):249-50. PubMed ID: 16739375
[TBL] [Abstract][Full Text] [Related]
37. Expression of fragile histidine triad (FHIT) and WW-domain oxidoreductase gene (WWOX) in nasopharyngeal carcinoma.
Chen X; Li P; Yang Z; Mo WN
Asian Pac J Cancer Prev; 2013; 14(1):165-71. PubMed ID: 23534718
[TBL] [Abstract][Full Text] [Related]
38. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K
Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846
[TBL] [Abstract][Full Text] [Related]
39. FHIT gene and flanking region on chromosome 3p are subjected to extensive allelic loss in Egyptian breast cancer patients.
Ismail HM; Medhat AM; Karim AM; Zakhary NI
Mol Carcinog; 2011 Aug; 50(8):625-34. PubMed ID: 21557333
[TBL] [Abstract][Full Text] [Related]
40. Expression of Fhit, Mlh1, and P53 protein in human gallbladder carcinoma.
Koda M; Yashima K; Kawaguchi K; Andachi H; Hosoda A; Shiota G; Ito H; Murawaki Y
Cancer Lett; 2003 Sep; 199(2):131-8. PubMed ID: 12969785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
